The layer under the racks that ARPA-H cannot buy
ARPA-H just committed $62 million to AI-guided heart failure care. The technology question is settled. The governance question is not.
ARPA-H committed $62 million this week to develop FDA-authorized AI for heart failure care. The model will be agentic. It will make recommendations. It will act.
The technology question is moving fast. The governance question is barely on the table.
I want to sit in that gap for a minute.
What governance actually means here
Governance is not a compliance checklist. It is not a policy binder. In the Sovereign Shield architecture, governance is a layer, and it sits under the infrastructure layer, not on top of it.
Most organizations build it the other way. They procure the compute. They stand up the model. They write the policies afterward, once someone asks for them. The policies live above the infrastructure as a kind of ceiling you hope the system never hits.
We built it inverted. Governance is the floor.
The reason is simple. A sovereign community, a tribal nation, a rural FQHC, has one thing no hyperscaler can replace: the authority to say no. To say whose data moves, where it moves, and on what terms. If you pour compute into a community before that authority is codified in the architecture itself, you have not given the community AI. You have given a vendor a new foothold.
That is not a criticism of ARPA-H. It is a structural fact about how infrastructure works when the procurement timeline moves faster than the governance conversation.
The three layers, and why the order matters
At Sovereign Shield, the architecture runs three layers deep.
The bottom layer is governance. Adaptive Inclusive Leadership Theory, AILT, developed through my doctoral research at Liberty University and field-tested across everything we have built. AILT holds four core constructs: Inclusive Adaptive Capacity, Participatory Sensemaking, Equity-Centered Flexibility, and Psychological Safety as the channel the other three travel through. The governance layer answers the question before the infrastructure question: who decides, and how do those decisions get made?
The middle layer is infrastructure. The Sovereign Prompt Shield, AES-256-GCM encryption on-device before AI processing, browser-edge identifier hashing, append-only audit logs, HIPAA-aligned client-side architecture. Raw PHI never crosses a wire it was not authorized to cross. The community holds the keys. The USPTO provisional patent is filed.
The top layer is product. Seventeen live deployments, including the Sovereign Health LLM fine-tuned at 97.78 percent accuracy on 41,000+ training pairs. Each product is the same architecture serving a different community.
Flip those layers and you get a very different company. You get a product company with some governance documentation stapled to the back. That company has no moat. Any hyperscaler can build the same product faster and cheaper. The moat in this architecture is the governance layer itself, because governance in a sovereign context is not a process. It is a right. And rights do not transfer.
What ARPA-H is actually paying for
The $62 million buys the model, the training, the clinical trial, the FDA pathway. That is real work and the heart failure problem is real. I know that personally. My wife’s father was found three days after a heart attack at 53. Wearable monitoring exists at Sovereign Shield because of him.
But the clinical AI question and the governance question are separate. A hospital system can receive an ARPA-H-funded AI agent for heart failure and still have no answer for who authorized the data pipeline that feeds it, which community voices shaped the training set, or what happens when the model recommends a treatment the community cannot access because the rural hospital is forty miles away and the specialist does not take Medicaid.
Governance answers those questions before deployment, not after a patient complaint surfaces them.
The practical consequence of building it inverted
When we deploy a node, the governance conversation happens first. Who sits in the room? Who has veto authority? What data stays local? What leaves, under what conditions, and who audits the log?
That conversation is slower than just standing up a container and handing over credentials. I will not pretend otherwise. The Cost of Consistency, one of the extension constructs in AILT, is real. Every governance rule we refuse to bend has a price. The price here is time and some friction at the start.
The bill you avoid paying is a community that trusted you, built clinical workflows around your system, and then discovered three years later that their patient data was aggregated somewhere upstream they never authorized. That bill is not paid in dollars. It is paid in the relationship between a tribal nation and every technology partner who approaches it for the next decade.
Pick up enough crumbs, you get a loaf of bread. Skip the governance layer to move faster and you are not picking up crumbs. You are sweeping the floor before anyone ate.
One question worth sitting with
ARPA-H is funding the intelligence. That is the right investment. But who is funding the governance architecture that decides how that intelligence operates inside a sovereign community?
That is the layer we are building in Ada. One node at a time.
Get the journal by email
One email when there is an entry. Nothing else. No pitch. Unsubscribe whenever you want.